Home » Topics » Regulatory

Regulatory
RSS

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...